Alterations of Several Serum Parameters Are Associated with Preeclampsia and May Be Potential Markers for the Assessment of PE Severity.
Journal
Disease markers
ISSN: 1875-8630
Titre abrégé: Dis Markers
Pays: United States
ID NLM: 8604127
Informations de publication
Date de publication:
2020
2020
Historique:
received:
10
09
2019
revised:
21
11
2019
accepted:
31
12
2019
entrez:
7
2
2020
pubmed:
7
2
2020
medline:
30
9
2020
Statut:
epublish
Résumé
The precise pathophysiological mechanisms of preeclampsia (PE) and preventative strategies remain unknown. Laboratory markers which can help in identifying PE patients from pregnant women and assessing the severity of PE during pregnancy are worthy to be explored. In this study, a retrospective case-control study was designed to assess whether the serum levels of albumin (ALB), total protein (TP), prealbumin (PA), alkaline phosphatase (ALP), lactic dehydrogenase (LDH), D-dimer, fibrinogen (Fbg), platelet (PLT) count, mean platelet volume (MPV), and platelet distribution width (PDW) can help in assessing PE and evaluate its severity. 256 pregnant women were enrolled and classified into 3 groups: mild preeclampsia (mPE,
Identifiants
pubmed: 32025276
doi: 10.1155/2020/7815214
pmc: PMC6983284
doi:
Substances chimiques
Biomarkers
0
Fibrin Fibrinogen Degradation Products
0
Prealbumin
0
fibrin fragment D
0
Fibrinogen
9001-32-5
L-Lactate Dehydrogenase
EC 1.1.1.27
Alkaline Phosphatase
EC 3.1.3.1
Types de publication
Journal Article
Retracted Publication
Langues
eng
Sous-ensembles de citation
IM
Pagination
7815214Commentaires et corrections
Type : RetractionIn
Informations de copyright
Copyright © 2020 Zhongliang Duan et al.
Déclaration de conflit d'intérêts
The authors declared no potential conflicts of interests with respect to the authorship and publication of this article.
Références
Int J Gynaecol Obstet. 2002 Apr;77(1):67-75
pubmed: 12094777
Obstet Gynecol Surv. 2007 Mar;62(3):191-201
pubmed: 17306041
J Clin Invest. 2016 Jul 1;126(7):2561-74
pubmed: 27270170
Eur J Obstet Gynecol Reprod Biol. 2019 Oct;241:19-23
pubmed: 31415952
Clin Exp Obstet Gynecol. 2015;42(1):26-31
pubmed: 25864277
Pregnancy Hypertens. 2018 Jul;13:174-180
pubmed: 30177049
J Obstet Gynaecol Can. 2011 Sep;33(9):922-6
pubmed: 21923989
Eur J Obstet Gynecol Reprod Biol. 2014 Apr;175:107-11
pubmed: 24502873
Annu Rev Pathol. 2010;5:173-92
pubmed: 20078220
Int J Gynaecol Obstet. 2005 Apr;89(1):51-2
pubmed: 15777901
J Womens Health (Larchmt). 2018 Dec;27(12):1519-1524
pubmed: 29920141
Pregnancy Hypertens. 2013 Jan;3(1):44-7
pubmed: 26105740
Biol Trace Elem Res. 2013 Jun;152(3):327-32
pubmed: 23526144
J Obstet Gynaecol Can. 2004 Oct;26(10):871-9
pubmed: 15507197
J Prenat Med. 2011 Oct;5(4):90-2
pubmed: 22905300
Pregnancy Hypertens. 2018 Oct;14:174-176
pubmed: 30527108
Arch Gynecol Obstet. 2018 Aug;298(2):405-413
pubmed: 29938347
Nat Med. 2006 Jun;12(6):642-9
pubmed: 16751767
Placenta. 2009 Jun;30(6):473-82
pubmed: 19375795
Placenta. 2017 Dec;60 Suppl 1:S41-S51
pubmed: 28647398
Ann Epidemiol. 2016 Dec;26(12):853-857.e1
pubmed: 27818017
Med Sci Monit. 2017 Nov 13;23:5396-5401
pubmed: 29129906
Hypertens Pregnancy. 2015 Nov;34(4):434-442
pubmed: 26362129
Clin Chim Acta. 2017 Jan;464:218-222
pubmed: 27919602
Clin Chim Acta. 2013 Feb 1;416:67-71
pubmed: 23159300
Am J Obstet Gynecol. 2008 Sep;199(3):266.e1-6
pubmed: 18771978
J Reprod Immunol. 2019 Apr;132:29-34
pubmed: 30861482
Eur J Epidemiol. 2013 Jan;28(1):1-19
pubmed: 23397514
J Reprod Immunol. 2014 Mar;101-102:120-126
pubmed: 24119981
Semin Nephrol. 2011 Jan;31(1):33-46
pubmed: 21266263
Vasc Health Risk Manag. 2016 Nov 21;12:477-480
pubmed: 27920548
Hematology. 2013 Nov;18(6):360-4
pubmed: 23676885
Am J Obstet Gynecol. 2018 Feb;218(2):211-218
pubmed: 29138037
J Reprod Immunol. 2015 Apr;108:42-7
pubmed: 25766966
J Perinat Med. 2018 Nov 27;46(9):1010-1015
pubmed: 29267172
J Clin Invest. 2003 Mar;111(5):649-58
pubmed: 12618519
Lancet. 2010 Aug 21;376(9741):631-44
pubmed: 20598363